Markus R Meyer - JoVE Visualize

Showing results (151-160 of 261) with videos related to

Pageof 27

Sort By:

Journal of Pharmaceutical and Biomedical Analysis|December 5, 2016

Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS<sup>n</sup>, and LC-HR-MS/MS approachesAchim T Caspar, Simon D Brandt, Andreas E Stoever, et al.

Analytical and Bioanalytical Chemistry|August 23, 2015

Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MSJulian A Michely, Andreas G Helfer, Simon D Brandt, et al.

Analytical and Bioanalytical Chemistry|July 4, 2016

Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approachesLilian H J Richter, Yeda Rumi Kaminski, Fozia Noor, et al.

Talanta|January 1, 2026

Capillary blood microsampling and LC-Orbitrap analysis for adherence monitoring of cardiovascular drugs: method development, cross-validation, and patient proof-of-concept using VAMS and Capitainer-BDiana Kretschmer, Mert Tokcan, Philipp Markwirth, et al.

Analytica Chimica Acta|April 4, 2017

Liquid chromatography-high resolution-tandem mass spectrometry using Orbitrap technology for comprehensive screening to detect drugs and their metabolites in blood plasmaAndreas G Helfer, Julian A Michely, Armin A Weber, et al.

Clinical Toxicology (Philadelphia, Pa.)|July 12, 2011

Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)Adrian Derungs, Simeon Schietzel, Markus R Meyer, et al.

Journal of Mass Spectrometry : JMS|February 26, 2009

New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniquesChristoph Sauer, Frank T Peters, Claudia Haas, et al.

Bioanalysis|November 19, 2010

Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbesAndy Zöllner, Daniela Buchheit, Markus R Meyer, et al.

Journal of Analytical Toxicology|February 6, 2020

Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-FentanylTanja M Gampfer, Lea Wagmann, Matthias J Richter, et al.

Journal of Pharmaceutical and Biomedical Analysis|July 4, 2016

3-Fluorophenmetrazine, a fluorinated analogue of phenmetrazine: Studies on in vivo metabolism in rat and human, in vitro metabolism in human CYP isoenzymes and microbial biotransformation in Pseudomonas Putida and wastewater using GC and LC coupled to (HR)-MS techniquesMarie Mardal, Bram Miserez, Richard Bade, et al.

Pageof 27

Showing results (151-160 of 261) with videos related to

Sort By:

Pageof 27

Journal of Pharmaceutical and Biomedical Analysis|December 5, 2016

Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS<sup>n</sup>, and LC-HR-MS/MS approachesAchim T Caspar, Simon D Brandt, Andreas E Stoever, et al.

Analytical and Bioanalytical Chemistry|August 23, 2015

Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MSJulian A Michely, Andreas G Helfer, Simon D Brandt, et al.

Analytical and Bioanalytical Chemistry|July 4, 2016

Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approachesLilian H J Richter, Yeda Rumi Kaminski, Fozia Noor, et al.

Talanta|January 1, 2026

Capillary blood microsampling and LC-Orbitrap analysis for adherence monitoring of cardiovascular drugs: method development, cross-validation, and patient proof-of-concept using VAMS and Capitainer-BDiana Kretschmer, Mert Tokcan, Philipp Markwirth, et al.

Analytica Chimica Acta|April 4, 2017

Liquid chromatography-high resolution-tandem mass spectrometry using Orbitrap technology for comprehensive screening to detect drugs and their metabolites in blood plasmaAndreas G Helfer, Julian A Michely, Armin A Weber, et al.

Clinical Toxicology (Philadelphia, Pa.)|July 12, 2011

Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)Adrian Derungs, Simeon Schietzel, Markus R Meyer, et al.

Journal of Mass Spectrometry : JMS|February 26, 2009

New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniquesChristoph Sauer, Frank T Peters, Claudia Haas, et al.

Bioanalysis|November 19, 2010

Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbesAndy Zöllner, Daniela Buchheit, Markus R Meyer, et al.

Journal of Analytical Toxicology|February 6, 2020

Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-FentanylTanja M Gampfer, Lea Wagmann, Matthias J Richter, et al.

Journal of Pharmaceutical and Biomedical Analysis|July 4, 2016

3-Fluorophenmetrazine, a fluorinated analogue of phenmetrazine: Studies on in vivo metabolism in rat and human, in vitro metabolism in human CYP isoenzymes and microbial biotransformation in Pseudomonas Putida and wastewater using GC and LC coupled to (HR)-MS techniquesMarie Mardal, Bram Miserez, Richard Bade, et al.

Pageof 27